Omniab Inc Stock Chance of Future Stock Price Finishing Over 3.90
| OABI Stock | USD 3.90 0.12 3.17% |
OmniAb |
OmniAb Target Price Odds to finish over 3.90
The tendency of OmniAb Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.90 | 90 days | 3.90 | about 84.13 |
Based on a normal probability distribution, the odds of OmniAb to move above the current price in 90 days from now is about 84.13 (This OmniAb Inc probability density function shows the probability of OmniAb Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.42 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, OmniAb will likely underperform. Additionally OmniAb Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. OmniAb Price Density |
| Price |
Predictive Modules for OmniAb
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OmniAb Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.OmniAb Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. OmniAb is not an exception. The market had few large corrections towards the OmniAb's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OmniAb Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OmniAb within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 1.42 | |
σ | Overall volatility | 0.25 | |
Ir | Information ratio | -0.08 |
OmniAb Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OmniAb for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OmniAb Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OmniAb Inc generated a negative expected return over the last 90 days | |
| OmniAb Inc currently holds 25.56 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. OmniAb Inc has a current ratio of 0.56, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about OmniAb's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 34.16 M. Net Loss for the year was (50.62 M) with profit before overhead, payroll, taxes, and interest of 59.08 M. | |
| About 69.0% of OmniAb shares are owned by institutional investors | |
| Latest headline from investing.com: OmniAbs SWOT analysis antibody discovery firms stock faces growth hurdles |
OmniAb Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OmniAb Stock often depends not only on the future outlook of the current and potential OmniAb's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OmniAb's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 99.7 M | |
| Cash And Short Term Investments | 87 M |
OmniAb Technical Analysis
OmniAb's future price can be derived by breaking down and analyzing its technical indicators over time. OmniAb Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OmniAb Inc. In general, you should focus on analyzing OmniAb Stock price patterns and their correlations with different microeconomic environments and drivers.
OmniAb Predictive Forecast Models
OmniAb's time-series forecasting models is one of many OmniAb's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary OmniAb's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about OmniAb Inc
Checking the ongoing alerts about OmniAb for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OmniAb Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| OmniAb Inc generated a negative expected return over the last 90 days | |
| OmniAb Inc currently holds 25.56 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. OmniAb Inc has a current ratio of 0.56, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about OmniAb's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 34.16 M. Net Loss for the year was (50.62 M) with profit before overhead, payroll, taxes, and interest of 59.08 M. | |
| About 69.0% of OmniAb shares are owned by institutional investors | |
| Latest headline from investing.com: OmniAbs SWOT analysis antibody discovery firms stock faces growth hurdles |
Check out OmniAb Backtesting, OmniAb Valuation, OmniAb Correlation, OmniAb Hype Analysis, OmniAb Volatility, OmniAb History as well as OmniAb Performance. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.